Assessment of Comparative Immunogenicity in Biosimilar Development: Immunogenicity and Pharmacokinetics Following a Single Dose of M923, a Proposed Biosimilar for Reference Adalimumab (HUMIRA (R)), Compared with US- and EU-Sourced Reference Adalimumab in Healthy Subjects

Published

Conference Paper

Full Text

Duke Authors

Cited Authors

  • Hillson, J; Mant, T; Ganguly, T; Avery, W; Rosano, M; Huntenburg, C; Palmer, D; Darne, S; Pavlova, B; Doralt, J; Reeve, R; Goel, N; Weilert, D; Rhyne, P; Caminis, J; Roach, J

Published Date

  • October 1, 2016

Published In

Volume / Issue

  • 68 /

Published By

Pages

  • 2

Electronic International Standard Serial Number (EISSN)

  • 2326-5205

International Standard Serial Number (ISSN)

  • 2326-5191